Effects of lifestyle activity modification on insulin resistance and pancreatic β-cells function in obese men with insulin resistance
الموضوعات : Journal of Physical Activity and HormonesMohadeseh Nematollahzadeh mahani 1 , Jalil Ghasemian poor 2
1 - The General Department of Fars Province Education
2 - The General Department of Fars Province Education
الکلمات المفتاحية: Insulin resistance, Obesity, Lifestyle activity modification, Pancreatic &beta, -cells function,
ملخص المقالة :
Introduction: Pancreatic β-cells function and insulin sensitivity resistance were impaired in type 2 diabetes. The effect of lifestyle activity modification (LAM) on these parameters is unclear. The aim of present study was to examine the effect of 8 weeks LAM on pancreatic β-cells function and insulin resistance in middle aged men with insulin resistance. Material & Methods: Sixteen obese and overweight middle aged men (age, 35-50 years) with insulin resistance participated in this study. The subjects were randomly assigned to LAM group (n=8) or control group (n=8). The subjects in LAM group walked 2 miles in 30 minutes on a treadmill on 4 days per week for 12 weeks according to the guidelines of the Centers for Disease Control and Prevention and American College of Sports Medicine. Results: The results indicated that fasting blood sugar, fasting insulin and insulin resistance index decreased and pancreatic β-cells function increased significantly after the intervention. Conclusion: In summary, it seems that LAM improves insulin resistance and pancreatic β-cells function in obese men with insulin resistance.
1. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci 2006; 1084: 89-117.
2. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006; 64: 355-365.
3. Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, et al. Harrison’s principles of internal medicine. New York: Mc Graw Hill Medical, 2008.
4. Centers for Disease Control and Prevention. National diabetes fact sheet: general Information and national estimates on diabetes in the United States Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2008), 2007. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf.
5. Bjornholt JV, Erikssen G, Liestol K, Jervell J, Thaulow E, Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low risk individuals: Results from 22.5 years of follow-up of healthy no diabetic men. Diabetes care 2000; 23: 1255-1259.
6. Bennett PH. Epidemiology of diabetes mellitus. In: LeRoith D, Talor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text. 3rd ed. Lippincott William & Wilkins, 2004.
7. Myers MG. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004; 59: 287-304.
8. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19.
9. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. U.K. Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002; 25: 330-336.
10. Guardado-Mendoza R, Jimenez-Ceja L, Majluf-Cruz A, Kamath S, Fiorentino TV, Casiraghi F, et al. Impact of obesity severity and duration on pancreatic β- and α-cell dynamics in normoglycemic non-human primates. Int J Obes (Lond) 2013; 37: 1071-1078.
11. Lee SC, Pervaiz S. Apoptosis in the pathophysiology of diabetes mellitus. Int J Biochem Cell Biol 2007. 39: 497-504.
12. Russo GT, Giorda CB, Cercone S, Nicolucci A, Cucinotta D. Beta Decline Study Group. Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. PLoS One 2014; 9:e109702.
13. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM,et al. Impact of aerobic exercise training on agerelated changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52: 1888-1896.
14. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab 2000; 85: 2463-2468.
15. Kahn SE, LarsonVG, Beard JC, Cain KC, Fellingham GW, Schwartz RS, et al. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 1990; 258: 937-943.
16. Kirwan JP, Kohrt WM,Wojta DM, Bourey RE, Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol 1993; 48: 84-90.
17. Omidi M, Moghadasi M. Regular aerobic training improves insulin resistance but not pancreatic β-cells function in female patients with type 2 diabetes. J Physic Act Horm 2017; 1: 59-70.
18. Farbod M, Sarpooshi A, Silakhory F. Short term aerobic training improves fasting glucose and beta cell function in obese/overweight women. Biol Forum 2014; 6: 264-267.
19. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C. Physical activity and public health, A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. J Am Med Associat 1995, 273, 402-407.
20. American Collage of Sport Medicine. Guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2005.
21. Neiman DC. Fitness and sports medicine: An introduction. Bull Publishing Company, 1990.
22. Rowland TW. Exercise testing. In: Development Exercise Physiology. Champaign, IL: Human Kinetics, 1996.
23. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
24. Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM. An examination of beta-cell function measures and their potential use for estimating beta-cell mass. Diabetes Obes Metab 2008; 4: 63-76.
25. Kasuga M. Insulin resistance and pancreatic β cell failure. J Clin Invest 2006; 116: 1756-1760.
26. Røder ME, Porte D, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 604-608.
27. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993; 76: 44-48.
28. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Investig 1997; 100: 1166-1173.
29. Nematollahzadeh M, Shirazi-nezhad R. High intensity endurance training improves metabolic syndrome in men with type 2 diabetes mellitus. J Physic Act Horm 2017; 3: 51-64.
30. Eskandary S, Rahimi E. Effects of eight weeks aerobic training, resistance training and concurrent training on the metabolic syndrome and HbA1c in men with type 2 diabetes. J Physic Act Horm 2017; 2: 51-64.
31. Way KL, Hackett DA, Baker MK, Johnson NA. The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Metab J 2016; 40: 253-271.
32. Bogardus C, Thuillez P, Ravussin E, Vasquez B, Narimiga M, Azhar S. Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest 1983; 72: 1605-1610.
33. Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Kashyap S, et al. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 2004; 53: 1233-1242.
34. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004; 53: 294-305.
35. Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med 2000; 21: 1-12.
36. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 2013; 93: 993-1017.
37. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol Respir Environ Exerc Physiol 1984; 56: 831-838.
38. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 2004; 47: 23-30.
39. Kraniou GN, Cameron-Smith D, Hargreaves M. Acute exercise and GLUT4 expression in human skeletal muscle: influence of exercise intensity. J Appl Physiol (1985) 2006; 101: 934-937.
40. Colberg SR, Albright AL, Blissmer BJ, Braun B, Chasan-Taber L, Fernhall B, et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc 2010; 42: 2282-2303.
41. Praet SF, van Loon LJ. Optimizing the therapeutic benefits of exercise in type 2 diabetes. J Appl Physiol (1985) 2007; 103: 1113-1120.
42. O'Gorman DJ, Karlsson HK, McQuaid S, Yousif O, Rahman Y, Gasparro D, et al. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia 2006; 49: 2983-2992.
43. Ha CH, Swearingin B, Jeon YK. Relationship of visfatin level to pancreatic endocrine hormone level, HOMA-IR index, and HOMA β-cell index in overweight women who performed hydraulic resistance exercise. J Phys Ther Sci 2015; 27: 2965-2969.
44. Kahn SE. The relative contributions telling us about diabetes. J Am Diet Assoc 2003; 108: 12-18.
45. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141.
46. Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. High Intensity Interval Training Improves Glycaemic Control and Pancreatic β Cell Function of Type 2 Diabetes Patients. PLoS One 2015; 10: 1-24.
47. Bakker SJ, Rg IJ, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000; 148: 17-21.
48. Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and β-cell function (HOMA) with weight loss in the severely obese. Diabet Med 2003; 20: 127-134.
49. Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, et al. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 1990; 70: 1594-1602.
50. Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus. Diabet Med 1994; 11: 71-78.
